Endoscopic Ultrasound Predict the Sensitivity of Stage II / III Rectal Cancer Preoperative Concurrent Chemoradiotherapy
NCT01582750 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2013-09-19
Summary
The purpose of this study is to determine the role of endoscopic ultrasound measurement of the primary tumor maximum diameter changes in absolute / relative values in predicting the tumor regression after concurrent chemoradiotherapy for rectal cancer.
Conditions
Sponsors & Collaborators
-
Chinese Academy of Medical Sciences
lead OTHER
Principal Investigators
-
Jing Jin, M.D. · Chinese Acedemy of Medical Sciences
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2014-09-30
- Completion
- 2015-12-31
Countries
- China
Study Locations
More Related Trials
-
Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer
NCT06293612 ·Status: COMPLETED
-
Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer
NCT01584544 ·Status: COMPLETED ·Phase: PHASE1
-
Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer
NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Preoperative (Chemo)Radiotherapy for Locally Recurrent Rectal Cancer
NCT06617052 ·Status: NOT_YET_RECRUITING
-
Change of Circulating Tumor Cells During Laparoscopic or Transanal Endoscopic Surgery for Rectal Cancer.
NCT05109130 ·Status: UNKNOWN
-
UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer
NCT05148767 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients
NCT01268943 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Intramural Spread Pattern in Low Rectal Cancer.
NCT07202169 ·Status: COMPLETED
-
A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-radiomics
NCT07107815 ·Status: ENROLLING_BY_INVITATION
-
Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors
NCT06566222 ·Status: NOT_YET_RECRUITING
-
Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT
NCT03068403 ·Status: COMPLETED ·Phase: NA
-
Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis
NCT02979795 ·Status: UNKNOWN
-
Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI
NCT02640586 ·Status: UNKNOWN ·Phase: NA
-
PET-CT and Circulating Tumor Cells in Colorectal Cancer
NCT01163305 ·Status: COMPLETED
-
Effects of Different Treatment for Anorectal Function of Patients With Rectal Cancer
NCT05671809 ·Status: NOT_YET_RECRUITING
-
Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer
NCT06879197 ·Status: COMPLETED
-
Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer
NCT06883084 ·Status: ENROLLING_BY_INVITATION
-
Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors
NCT03177382 ·Status: UNKNOWN ·Phase: PHASE3
-
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
NCT01549067 ·Status: UNKNOWN
-
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer
NCT02528175 ·Status: COMPLETED ·Phase: NA
-
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
NCT06949098 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Different Radiation Dosimetry for Anorectal Function of Patients With Pelvic Cancer
NCT05832385 ·Status: NOT_YET_RECRUITING
-
A Study for Short Preoperative Chemoradiotherapy for Resectable Rectal Carcinoma
NCT00973778 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficiency of Photodynamic Therapy for Rectal Cancer
NCT01872104 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer
NCT05368051 ·Status: UNKNOWN